Able Laboratories Inc (857171) SEC Filing 8-K Material Event for the period ending Monday, July 17, 2006

Able Laboratories Inc

CIK: 857171

View differences made from one to another to evaluate Able Laboratories Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Able Laboratories Inc.


Assess how Able Laboratories Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Able Laboratories Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2006 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools
CIK: 857171
Form Type: 8-K Corporate News
Accession Number: 0000914121-06-002441
Submitted to the SEC: Fri Jul 21 2006 2:38:44 PM EST
Accepted by the SEC: Fri Jul 21 2006
Period: Monday, July 17, 2006
Industry: In Vitro And In Vivo Diagnostic Substances
  1. Bankruptcy or Receivership
  2. Financial Exhibit

External Resources:

Bookmark the Permalink: